Cancer Moonshot℠ - Obligations by Budget Mechanism
With over $124 million obligated for Cancer Moonshot activities in fiscal year 2023, funding was allocated into four budget mechanisms: research grants, research and development (R&D) contracts, intramural research, and research management and support, as shown in the chart below.
Includes new obligations and recoveries from fiscal years 2017, 2018, 2019, 2020, 2021 and 2022 carryover accounts.
| Type of Mechanism | Mechanism | Number | Amount* |
|---|---|---|---|
| Research Project Grants (RPGs) | Competing | 17 | $10,107,821 |
| Noncompeting | 27 | $23,509,144 | |
| Administrative Supplements | 0 | $4,429,604 | |
| Subtotal, without SBIR | 39 | $38,046,569 | |
| SBIR/STTR Grants | 2 | $947,801 | |
| Subtotal, RPGs | 46 | $38,994,370 | |
| Centers | Cancer Centers Grants-P30s | 0 | $3,269,673 |
| P50s | 11 | $11,971,432 | |
| Cooperative Agreements-U54s/U41s | 10 | $7,502,754 | |
| Subtotal, Centers | 21 | $22,743,859 | |
| Other Research | Resource Grants-U24s/U2Cs | 13 | $29,363,630 |
| Subtotal, Other Research | 13 | $29,363,630 | |
| Subtotal, Research Grants | 84 | $91,101,859 | |
| Intramural Research | IR Program | 0 | $7,086,652 |
| Research Management & Support | RMS | 0 | $236,744 |
| R&D Contracts | R&D Contracts | 14 | $19,241,154 |
| SBIR/STTR Contracts | 3 | $6,739,920 | |
| Subtotal, R&D Contracts | 17 | $25,981,074 | |
| Total | $124,406,329 | ||
| * Includes new obligations and recoveries from fiscal years 2017, 2018, 2019, 2020, and 2021 carryover accounts. | |||